Stock market anomaly | Odyssey Therapeutics (ODTX.US) lands on the US stock market, opening stock price fluctuates slightly

According to the interface finance APP, on Friday, Odyssey Therapeutics (ODTX.US) made its debut on the US stock market, with the opening stock price showing little fluctuation, priced at $18. As of the time of writing, the stock has dropped by over 1%, trading at $17.81. Odyssey Therapeutics is a clinical-stage biotechnology company headquartered in Boston, U.S., focusing mainly on the research and development of drugs for autoimmune and inflammatory diseases. The company's core product is OD-001, a small molecule drug for the treatment of ulcerative colitis, which has already entered into mid-stage clinical trials. In addition, the company is also developing pipelines for multiple immune diseases such as lupus and eczema.